Franciszek Dłuski Dominik, Mierzyński Radzisław, Poniedziałek-Czajkowska Elżbieta, Leszczyńska-Gorzelak Bożena
Chair and Department of Obstetrics and Perinatology, Medical University of Lublin, 20-954 Lublin, Lubelskie Region, Poland.
Cancers (Basel). 2020 Dec 16;12(12):3795. doi: 10.3390/cancers12123795.
The frequency of concomitant adnexal tumors in pregnancy is reported to be at 0.15-5.7%, while ovarian cancer complicates 1 in 15,000 to 1 in 32,000 pregnancies, being the second most common gynecologic cancer diagnosed during pregnancy. The aim of this review is to discuss the problem of ovarian cancer complicating pregnancy and the current recommendations for diagnostics and treatment, with an emphasis on the risk to the fetus. A detailed analysis of the literature found in the PubMed and MEDLINE databases using the keywords "ovarian cancer", "ovarian malignancy", "adnexal masses", "ovarian tumor" and "pregnancy" was performed. There were no studies on a large series of pregnant women treated for ovarian malignancies and the management has not been well established. The diagnostics and therapeutic procedures need to be individualized with respect to the histopathology of the tumor, its progression, the gestational age at the time of diagnosis and the mother's decisions regarding pregnancy preservation. The multidisciplinary cooperation of specialists in perinatal medicine, gynecological oncology, chemotherapy, neonatology and psychology seems crucial in order to obtain the best possible maternal and neonatal outcomes.
据报道,孕期合并附件肿瘤的发生率为0.15% - 5.7%,而卵巢癌在每15,000至32,000次妊娠中会使1例妊娠复杂化,是孕期诊断出的第二常见妇科癌症。本综述的目的是讨论妊娠合并卵巢癌的问题以及当前的诊断和治疗建议,重点关注对胎儿的风险。使用关键词“卵巢癌”“卵巢恶性肿瘤”“附件肿块”“卵巢肿瘤”和“妊娠”对PubMed和MEDLINE数据库中的文献进行了详细分析。目前尚无关于大量接受卵巢恶性肿瘤治疗的孕妇的研究,且管理方法尚未完全确立。诊断和治疗程序需要根据肿瘤的组织病理学、进展情况、诊断时的孕周以及母亲关于保留妊娠的决定进行个体化。围产医学、妇科肿瘤学、化疗、新生儿学和心理学专家的多学科合作对于获得最佳的母婴结局似乎至关重要。